Harrow, Inc. APIC, Share-based Payment Arrangement, Increase for Cost Recognition
Harrow, Inc. (HROW) reported APIC, Share-based Payment Arrangement, Increase for Cost Recognition of $3.79 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements
us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue · last filed 2026-08-10
- Harrow, Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-06-30 was $3.79M, a 332.91% increase year-over-year.
- Harrow, Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-03-31 was $3.84M, a 15.78% decline year-over-year.
- Harrow, Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-12-31 was $3.80M, a 20.73% decline year-over-year.
- Harrow, Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-09-30 was $3.27M, a 25.40% decline year-over-year.
- Harrow, Inc. apic, share-based payment arrangement, increase for cost recognition for fiscal 2025 was $12.50M, a 29.04% decline from fiscal 2024.
- Harrow, Inc. apic, share-based payment arrangement, increase for cost recognition for fiscal 2024 was $17.62M, a 12.25% increase from fiscal 2023.
- Harrow, Inc. apic, share-based payment arrangement, increase for cost recognition for fiscal 2023 was $15.70M, a 96.84% increase from fiscal 2022.
- Harrow, Inc. apic, share-based payment arrangement, increase for cost recognition for fiscal 2022 was $7.97M, a 38.80% increase from fiscal 2021.
| Period end | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 9 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 12 month |
|---|---|---|---|---|
| 2026-06-30 | $3.79M 10-Q · filed 2026-08-10 | $7.63M 10-Q · filed 2026-08-10 | $11.43M derived: sum of 3 quarters · filed 2026-08-10 | $14.70M derived: sum of 4 quarters · filed 2026-08-10 |
| 2026-03-31 | $3.84M 10-Q · filed 2026-05-11 | $7.64M derived: sum of 2 quarters · filed 2026-05-11 | $10.91M derived: sum of 3 quarters · filed 2026-05-11 | $11.78M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-12-31 | $3.80M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $7.07M derived: sum of 2 quarters · filed 2026-03-02 | $7.95M derived: sum of 3 quarters · filed 2026-08-10 | $12.50M 10-K · filed 2026-03-02 |
| 2025-09-30 | $3.27M 10-Q · filed 2025-11-10 | $4.15M derived: sum of 2 quarters · filed 2026-08-10 | $8.70M 10-Q · filed 2025-11-10 | $13.50M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-06-30 | $875.00K 10-Q · filed 2026-08-10 | $5.43M 10-Q · filed 2026-08-10 | $10.22M derived: sum of 3 quarters · filed 2026-08-10 | $14.61M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-03-31 | $4.56M 10-Q · filed 2026-05-11 | $9.35M derived: sum of 2 quarters · filed 2026-05-11 | $13.73M derived: sum of 3 quarters · filed 2026-05-11 | $18.01M derived: sum of 4 quarters · filed 2026-05-11 |
| 2024-12-31 | $4.79M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $9.18M derived: sum of 2 quarters · filed 2026-03-02 | $13.45M derived: sum of 3 quarters · filed 2026-03-02 | $17.62M 10-K · filed 2026-03-02 |
| 2024-09-30 | $4.38M 10-Q · filed 2025-11-10 | $8.66M derived: sum of 2 quarters · filed 2025-11-10 | $12.82M 10-Q · filed 2025-11-10 | $17.00M derived: sum of 4 quarters · filed 2026-03-02 |
| 2024-06-30 | $4.27M 10-Q · filed 2025-08-11 | $8.44M 10-Q · filed 2025-08-11 | $12.62M derived: sum of 3 quarters · filed 2026-03-02 | $17.09M derived: sum of 4 quarters · filed 2026-03-02 |
| 2024-03-31 | $4.17M 10-Q · filed 2025-05-08 | $8.34M derived: sum of 2 quarters · filed 2026-03-02 | $12.82M derived: sum of 3 quarters · filed 2026-03-02 | $18.23M derived: sum of 4 quarters · filed 2026-03-02 |
| 2023-12-31 | $4.17M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $8.65M derived: sum of 2 quarters · filed 2026-03-02 | $14.06M derived: sum of 3 quarters · filed 2026-03-02 | $15.70M 10-K · filed 2026-03-02 |
| 2023-09-30 | $4.48M 10-Q · filed 2024-11-14 | $9.89M derived: sum of 2 quarters · filed 2024-11-14 | $11.52M 10-Q · filed 2024-11-14 | $13.55M derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | $5.41M 10-Q · filed 2024-08-07 | $7.04M 10-Q · filed 2024-08-07 | $9.08M derived: sum of 3 quarters · filed 2024-08-07 | $11.01M derived: sum of 4 quarters · filed 2024-08-07 |
| 2023-03-31 | $1.63M 10-Q · filed 2024-05-13 | $3.67M derived: sum of 2 quarters · filed 2024-05-13 | $5.60M derived: sum of 3 quarters · filed 2024-05-13 | $7.59M derived: sum of 4 quarters · filed 2024-05-13 |
| 2022-12-31 | $2.03M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-19 | $3.96M derived: sum of 2 quarters · filed 2024-03-19 | $5.96M derived: sum of 3 quarters · filed 2024-03-19 | $7.97M 10-K · filed 2024-03-19 |
| 2022-09-30 | $1.93M 10-Q · filed 2023-11-13 | $3.92M derived: sum of 2 quarters · filed 2023-11-13 | $5.94M 10-Q · filed 2023-11-13 | $8.06M derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | $1.99M 10-Q · filed 2023-08-09 | $4.01M 10-Q · filed 2023-08-09 | $6.12M derived: sum of 3 quarters · filed 2023-08-09 | $7.82M derived: sum of 4 quarters · filed 2023-08-09 |
| 2022-03-31 | $2.02M 10-Q · filed 2023-05-11 | $4.13M derived: sum of 2 quarters · filed 2023-05-11 | $5.83M derived: sum of 3 quarters · filed 2023-05-11 | $6.91M derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | $2.12M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23 | $3.81M derived: sum of 2 quarters · filed 2023-03-23 | $4.89M derived: sum of 3 quarters · filed 2023-03-23 | $5.75M 10-K · filed 2023-03-23 |
| 2021-09-30 | $1.70M 10-Q · filed 2022-11-14 | $2.77M derived: sum of 2 quarters · filed 2022-11-14 | $3.63M 10-Q · filed 2022-11-14 | $4.41M derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | $1.08M 10-Q · filed 2022-08-09 | $1.93M 10-Q · filed 2022-08-09 | $2.71M derived: sum of 3 quarters · filed 2022-08-09 | $3.63M derived: sum of 4 quarters · filed 2022-08-09 |
| 2021-03-31 | $855.00K 10-Q · filed 2022-05-05 | $1.64M derived: sum of 2 quarters · filed 2022-05-05 | $2.55M derived: sum of 3 quarters · filed 2022-05-05 | $3.10M derived: sum of 4 quarters · filed 2022-05-05 |
| 2020-12-31 | $780.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | $1.70M derived: sum of 2 quarters · filed 2022-03-10 | $2.24M derived: sum of 3 quarters · filed 2022-03-10 | $2.77M 10-K · filed 2022-03-10 |
| 2020-09-30 | $917.00K 10-Q · filed 2021-11-09 | $1.46M derived: sum of 2 quarters · filed 2021-11-09 | $2.00M 10-Q · filed 2021-11-09 | $2.38M derived: sum of 4 quarters · filed 2021-11-09 |
| 2020-06-30 | $545.00K 10-Q · filed 2021-08-10 | $1.08M 10-Q · filed 2021-08-10 | $1.46M derived: sum of 3 quarters · filed 2021-08-10 | $1.79M derived: sum of 4 quarters · filed 2021-08-10 |
| 2020-03-31 | $533.00K 10-Q · filed 2021-05-11 | $914.00K derived: sum of 2 quarters · filed 2021-05-11 | $1.24M derived: sum of 3 quarters · filed 2021-05-11 | $1.61M derived: sum of 4 quarters · filed 2021-05-11 |
| 2019-12-31 | $381.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-08 | $709.00K derived: sum of 2 quarters · filed 2021-03-08 | $1.08M derived: sum of 3 quarters · filed 2021-03-08 | $1.79M 10-K · filed 2021-03-08 |
| 2019-09-30 | $328.00K 10-Q · filed 2020-11-09 | $695.00K derived: sum of 2 quarters · filed 2020-11-09 | $1.41M 10-Q · filed 2020-11-09 | $1.94M derived: sum of 4 quarters · filed 2020-11-09 |
| 2019-06-30 | $367.00K 10-Q · filed 2020-08-10 | $1.08M 10-Q · filed 2020-08-10 | $1.62M derived: sum of 3 quarters · filed 2020-08-10 | $2.21M derived: sum of 4 quarters · filed 2020-08-10 |
| 2019-03-31 | $713.00K 10-Q · filed 2020-05-11 | $1.25M derived: sum of 2 quarters · filed 2020-05-11 | $1.84M derived: sum of 3 quarters · filed 2020-05-11 | $2.45M derived: sum of 4 quarters · filed 2020-05-11 |
| 2018-12-31 | $536.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-13 | $1.13M derived: sum of 2 quarters · filed 2020-03-13 | $1.73M derived: sum of 3 quarters · filed 2020-03-13 | $2.49M 10-K · filed 2020-03-13 |
| 2018-09-30 | $590.00K 10-Q · filed 2019-11-13 | $1.20M derived: sum of 2 quarters · filed 2019-11-13 | $1.95M 10-Q · filed 2019-11-13 | |
| 2018-06-30 | $608.00K 10-Q · filed 2019-08-14 | $1.36M 10-Q · filed 2019-08-14 | ||
| 2018-03-31 | $751.00K 10-Q · filed 2019-05-09 | |||
| 2017-12-31 | $2.88M 10-K · filed 2019-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| OPKO HEALTH, INC. (OPK) | United States | $1.220B | -15.59 |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| Kardigan, Inc. (KARD) | United States | $1.346B |